Procedural Glycoprotein IIb/IIIa inhibitor (GPIIb/IIIa) use in patients with ST-elevation myocardial infraction (STEMI) who undergo primary percutaneous coronary intervention (PPCI) without clopidogrel pretreatment

Authors :: Michael Mok
Stephen J. Duffy
David J Clark
Nick Adrianopoulos
Thomas Yip
Christopher M. Reid
James A. Black
Alexander Black
Gishel New
Andrew E. Ajani
Source :: Heart, Lung and Circulation. 18:S228-S229
Publication Year :: 2009
Publisher :: Elsevier BV, 2009.

Subjects :: Pulmonary and Respiratory Medicine
medicine.medical_specialty
business.industry
ST elevation
medicine.medical_treatment
Percutaneous coronary intervention
Clopidogrel
GpIIb/IIIa
Internal medicine
medicine
Cardiology
In patient
Cardiology and Cardiovascular Medicine
Glycoprotein IIb/IIIa
business
medicine.drug

Full Text Access

Tools